BioCryst Pharmaceuticals
BCRX
#4898
Rank
NZ$3.61 B
Marketcap
NZ$14.16
Share price
-1.85%
Change (1 day)
16.96%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$1.80 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$1.80 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$1.09 B-36.18%
2024-12-31NZ$1.71 B11.43%
2023-12-31NZ$1.53 B15.6%
2022-12-31NZ$1.33 B30.71%
2021-12-31NZ$1.01 B107.45%
2020-12-31NZ$0.49 B141.11%
2019-12-31NZ$0.20 B39.83%
2018-12-31NZ$0.14 B9.37%
2017-12-31NZ$0.13 B4.41%
2016-12-31NZ$0.12 B16.86%
2015-12-31NZ$0.10 B39.52%
2014-12-31NZ$78.15 M28.48%
2013-12-31NZ$60.83 M-13.56%
2012-12-31NZ$70.37 M-18.51%
2011-12-31NZ$86.36 M51.62%
2010-12-31NZ$56.96 M-26.02%
2009-12-31NZ$76.99 M16.77%
2008-12-31NZ$65.93 M-35.09%
2007-12-31NZ$0.10 B51.2%
2006-12-31NZ$67.18 M12.53%
2005-12-31NZ$59.7 M1259.2%
2004-12-31NZ$4.39 M73.22%
2003-12-31NZ$2.53 M13.24%
2002-12-31NZ$2.23 M-59.26%
2001-12-31NZ$5.49 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
NZ$67.00 B 3,616.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$105.17 B 5,733.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.95 B 64.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.49 B-17.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.04 B 13.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.12 B-93.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$1.89 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$18.52 M-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.38 B-23.39%๐Ÿ‡บ๐Ÿ‡ธ USA